LYB

Business profile & competitive position

LyondellBasell Industries N.V. is classified under Basic Materials in the Chemicals – Specialty industry. In plain terms, it is a global petrochemical and plastics producer, turning olefins, polyolefins and intermediates into the resins, fuels and refined products used across packaging, autos, construction and consumer goods. Specialty chemical businesses are normally expected to earn above-commodity margins through product differentiation or scale, but LYB’s recent financials do not show that kind of pricing power right now. The company’s net margin is negative 1.1% and return on equity is negative 3.4%, meaning the business is currently earning less than its cost of equity and destroying shareholder value on a trailing basis. A negative ROE undercuts the idea of a strong competitive moat in the current cycle; instead, the numbers point to an industry player being squeezed by oversupply, weak pricing, or high feedstock volatility. The market capitalization of $20.2 billion still reflects scale and asset base, yet the lack of positive profitability means the investment case cannot rest on durable quality alone. Beta sits at 0.35, which is typical for a mature materials company whose equity moves less dramatically than the broader market, but that low systematic risk does not protect against earnings-driven repricing or commodity-cycle drawdowns.

Financial posture

LYB’s valuation metrics today are dominated by the fact that it is losing money on net income. The P/E ratio is negative 55.9, which is not a valuation premium; it is simply the mathematical result of negative trailing earnings. Net margin of negative 1.1% and ROE of negative 3.4% confirm that the income statement is under pressure. That makes traditional earnings-based valuation almost useless for a quick read, and it forces investors toward normalized cash-flow, replacement-cost or asset-based frameworks. On the technical side, the stock closed at $62.65 with an RSI of 57.1, just above neutral, and sits above its 50-day exponential moving average of $61.20. The recent value-oriented news flow put a GF Value estimate of $72.71 against a price of $59.59 on August 7, which is the kind of divergence value screens flag. However, a “cheap” statistical label does not guarantee a floor; it only tells you that the current price is far below one model’s estimate of fair value. With negative margins and negative returns, the market is effectively saying it needs evidence that profitability can inflect before it will award a richer multiple. The $20.2 billion market cap still prices in a recovery, but the current financial posture is one of a company that must prove it can earn its cost of capital again.

Macro & geopolitical exposure

As a Specialty Chemicals name, LyondellBasell’s economics are tightly linked to the global commodity stack and industrial demand. Hydrocarbon feedstock costs—especially oil and natural gas liquids—are a major input swing factor; when naphtha or ethane prices spike, chemical margins compress unless product pricing can be passed through. Demand is cyclical, tied to autos, construction, packaging and durable goods, so any slowdown in those end markets flows quickly into volume and pricing. Trade policy matters because chemicals are globally traded goods: tariffs, anti-dumping duties or regional oversupply can reshape margins and export competitiveness. Currency exposure is unavoidable for a multinational with operations and sales across Europe, Asia and the Americas. Regulation is another persistent variable, ranging from emissions rules to plastics-recycling mandates and so-called extended producer-responsibility laws, all of which can require capital spending or alter demand for virgin plastics. Finally, supply-chain logistics—shipping rates, port congestion and plant outages—can move near-term earnings sharply. The recent mention of a “prolonged supply reset” fits squarely into this macro lens: the industry appears to be working through excess capacity, which is exactly the kind of cyclical condition that pressures margins across the sector.

Recent developments

The news tape in early August framed LYB as a value candidate under short-term pressure. On August 7, GuruFocus noted a 3.0% decline and put GuruFocus Value at $72.71 versus a price of $59.59. Two days earlier, on August 5, the same source asked whether LYB was a bargain after a 3.4% drop and labeled it undervalued. Meanwhile, on August 6, Defense World reported that Empowered Funds LLC had boosted its stock holdings in LyondellBasell, a sign that at least one institutional manager was adding exposure during the decline. On August 3, Zacks summarized the Q2 earnings call as pointing to a “prolonged supply reset,” a phrase that should carry more weight than the value headlines because it describes the operating environment management expects to navigate. Taken together, the recent narrative is split between value-screen optimism and an industry-specific warning that excess supply may take time to clear. The current price of $62.65 sits between the August low referenced around $59.59 and the GF Value reference of $72.71, suggesting the market is still debating whether the supply reset is close to a base or has further to run.

Earnings behavior & post-earnings drift

LYB’s earnings record is a useful case study in why headline beats and misses do not always translate into directional price follow-through. Over the last eight reported quarters, the company has beaten estimates exactly four times, for a 50% beat rate, and the average earnings surprise is a negative 28.6%. That negative average surprise means estimates have generally been too high, even though half the releases beat. More striking is the average five-day post-earnings move: negative 0.8%, classified as a “down” drift.

The last four quarters make this disconnect concrete. On July 31, 2026, LYB reported $4.30 versus an estimate of $3.44, a 25% beat, yet the stock fell 2.35% the next day and 4.01% over the following five days. On May 1, 2026, the company beat by 74.6% with actual EPS of $0.49 against $0.2806, but after a 1.4% one-day pop it gave back 4.31% over five days. On October 31, 2025, a 24.5% beat ($1.01 vs. $0.811) produced a 0.32% next-day decline and a 7.32% five-day slide. The pattern is so consistent that it qualifies as the “beat = pop and hold” myth in action: LYB has often sold off after beats. The exception that proves the rule came on January 30, 2026, when LYB missed by 333.6% with actual EPS of negative $0.26 versus an estimate of $0.1113; that terrible miss was followed by a 2.55% next-day gain and a 12.45% rally over five days. The market apparently looked through the miss to future supply discipline or low expectations.

Looking ahead, the next scheduled earnings release is October 30, 2026, before the open, with a consensus EPS estimate of $2.81. The official estimate matters, but the post-earnings track record suggests that the market’s real expectation hinges at least as much on commentary around the supply reset, guidance and macro outlook as on whether the reported number clears the consensus bar. With RSI at 57.1 and price just above the 50-day EMA, the setup is not at an extreme, so an earnings catalyst could still generate a meaningful move despite the stock’s low 0.35 beta.

For a deeper look at how institutional analysts are modeling the supply reset, margin recovery path and normalized valuation, readers should examine the full institutional verdict on the name.